COVID‐19 mRNA vaccine‐related interstitial lung disease: Two case reports and literature review

The Pfizer‐BioNTech mRNA vaccine (BNT162b2) is an effective and well‐tolerated coronavirus disease 2019 (COVID‐19) vaccine. However, rare adverse events have been reported. We report two cases of COVID‐19 mRNA vaccine‐related interstitial lung disease (ILD). A 67‐year‐old man and a 70‐year‐old man w...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Clara, Izumi, Shinyu, Ishida, Akane, Hirakawa, Ryo, Kusaba, Yusaku, Hashimoto, Masao, Ishii, Satoru, Miyazaki, Hideki, Iikura, Motoyasu, Hojo, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942814/
https://www.ncbi.nlm.nih.gov/pubmed/35355663
http://dx.doi.org/10.1002/rcr2.938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942814/
https://www.ncbi.nlm.nih.gov/pubmed/35355663
http://dx.doi.org/10.1002/rcr2.938

Ejemplares similares